Mild COVID cases mount strong immune defense, study finds
NCT ID NCT04703114
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examined how people with mild or no COVID-19 symptoms respond to the virus. Researchers measured immune markers in the blood of 57 adults who tested positive. The goal was to understand why some people clear the virus quickly while others develop severe illness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Cochin
Paris, Île-de-France Region, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a five-day pill course cut COVID-19 deaths? czech nationwide data puts molnupiravir to the test.
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- E-Ink screens in ERs could boost patient satisfaction
- Millions of vaccine records scoured for rare side effects
- Massive study tracks how lockdowns shaped mental health across america
- Scientists probe why lung disease raises COVID-19 risk